🇺🇸 FDA
Patent

US 10774121

Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease and improving normal memory

granted A61KA61K38/00A61K38/08

Quick answer

US patent 10774121 (Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease and improving normal memory) held by The Regents of the University of California expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/00, A61K38/08, A61K38/10, A61K38/1709